|
Special Issues in HIV Care: 2008 Update
In
the past year, several new antiretroviral agents, some with different
mechanisms of action, have been introduced. For many people, these new treatments offer new hope and
improved quality of life. However, it is also a challenging time as more data
accumulate on tolerability and toxicity issues, viral resistance, and changing treatment
guidelines. While antiretroviral therapies can achieve undetectable
blood levels of the HIV virus, effective treatment and favorable clinical
outcomes are often hindered by coinfections; behavioral, socioeconomic, and cultural
factors; and access to care.
Please click here to view a webinar of the 2008 USCA seminar, Special Issues in HIV Care: 2008 Update, which discusses up-to-date information on HIV management, particularly newly approved medications and will also address those populations disproportionately affected by
HIV and at high risk for increased morbidity and mortality from HIV/AIDS.
|
|
Special Issues in HIV Care
Whether due to economic issues, access to care, sociocultural values and beliefs, or communication barriers, eliminating disparities in HIV/AIDS care among minority populations and certain groups remains an important goal for health-care providers, policy makers, and treatment advocates.
While individuals with HIV share many of the key issues and challenges of living with HIV/AIDS, effective HIV prevention and care obligates the recognition and thorough understanding of specific issues that are unique to a group.
Click here to download a PDF of the Special Issues in HIV Care Breakfast Seminar, presented at the 2007 United States Conference on AIDS, through an educational grant from Merck & Co., Inc. This
seminar explores the specific healthcare needs of several groups and
outlines disease-, epidemiology-, and population-specific treatment
strategies to optimize patient outcomes, and reviews the role of
new therapeutic agents.
|
